Pacemaker use rose more than 50% between 1993 and 2009, but most of that occurred prior to 2002, a new study shows.
MASSDEVICE ON CALL — A study of pacemaker usage confirmed what most medical device makers already know all too well - the U.S. cardiac rhythm management market just isn't what is used to be.
Stagnancy in the CRM arena has been an anchor weighing down many of the largest medical device makers, including rival medical device makers St. Jude Medical (NYSE:STJ) and Boston Scientific (NYSE:BSX), both of which have lamented the sluggish market and its impact on their quarterly earnings.
Pacemaker use increased 56% between 1993 and 2009, but most of that occurred in the 1990s and has leveled off since hitting a growth peak in 2001, according to a Reuters Health report.
Meanwhile, pacemaker patients have gotten older and sicker, the median age of a dual-chamber pacemaker recipient rising from 73 to 75 years old and exhibiting more co-morbidities than in 1993, according to the newswire.
"The overall market is down in the U.S., but we do see that implant volume is growing," Ishrak said during a conference call with investors last month. "We were pleased to see relative sequential stability in the market."
Here's a look at some of the top regulatory stories for medical device companies this week.
Ulthera, which makes an ultrasound device designed to lift lax tissue on the neck and under the chin...
Dr. George Bakris, co-principal investigator in Medtronic's Symplicity-3 trial, says renal...
Delivering Medical Extrusions in 3-5 days - Fast & Flexible
A federal appeals court stays a ban on U.S. sales of Medtronic's CoreValve replacement heart valve...